NR565 EXAM 1: ADVANCED
PHARMACOLOGY FOUNDATIONS
QUESTIONS AND VERIFIED ANSWERS
|GRADE A+|CHAMBERLAIN COLLEGE
1. Which process describes the movement of a drug from its site of administration into the
blood?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Answer: C
Conceptual Explanation: Absorption is the movement of a drug from its site of
administration into the blood. Distribution is the movement from blood to tissues,
metabolism is enzymatic alteration, and excretion is removal from the body.
2. A patient is taking a drug that is a known CYP450 enzyme inducer. How will this affect a co-
administered drug that is metabolized by the same enzyme?
A. The plasma levels of the second drug will decrease.
B. The plasma levels of the second drug will increase.
,C. The half-life of the second drug will increase.
D. There will be no change in the second drug’s metabolism.
Answer: A
Conceptual Explanation: Enzyme inducers increase the rate of drug metabolism, which
leads to lower plasma levels of the substrate drug and potentially reduced therapeutic
effect.
3. Which of the following describes the ‘First-Pass Effect’?
A. The rapid renal excretion of a drug after the first dose.
B. The binding of a drug to albumin during its first circuit through the blood.
C. The initial distribution of a drug to highly perfused organs like the heart.
D. The inactivation of oral drugs by liver enzymes before they reach systemic circulation.
Answer: D
Conceptual Explanation: The first-pass effect refers to the rapid hepatic inactivation of
certain oral drugs. When drugs are absorbed from the GI tract, they go directly to the liver
via the hepatic portal vein; if the liver has a high capacity to metabolize them, they can be
entirely inactivated.
4. A drug with a narrow therapeutic index (TI) requires which of the following clinical actions?
A. Minimal monitoring since the drug is very safe.
B. Administration of the drug only via the intravenous route.
, C. Frequent monitoring of serum drug levels to avoid toxicity.
D. Use of the drug only in emergency situations.
Answer: C
Conceptual Explanation: A narrow therapeutic index means the lethal or toxic dose is
close to the therapeutic dose. Therefore, careful monitoring of blood levels is necessary to
ensure safety.
5. Which receptor sub-type is primarily responsible for increasing heart rate and contractility?
A. Beta-1
B. Alpha-1
C. Beta-2
D. Muscarinic-2
Answer: A
Conceptual Explanation: Beta-1 receptors are located primarily in the heart. Activation
leads to increased heart rate (chronotropy) and increased force of contraction (inotropy).
6. What is the primary physiological effect of activating Alpha-1 receptors?
A. Vasodilation of skeletal muscle arterioles
B. Vasoconstriction of blood vessels
C. Bronchodilation
PHARMACOLOGY FOUNDATIONS
QUESTIONS AND VERIFIED ANSWERS
|GRADE A+|CHAMBERLAIN COLLEGE
1. Which process describes the movement of a drug from its site of administration into the
blood?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Answer: C
Conceptual Explanation: Absorption is the movement of a drug from its site of
administration into the blood. Distribution is the movement from blood to tissues,
metabolism is enzymatic alteration, and excretion is removal from the body.
2. A patient is taking a drug that is a known CYP450 enzyme inducer. How will this affect a co-
administered drug that is metabolized by the same enzyme?
A. The plasma levels of the second drug will decrease.
B. The plasma levels of the second drug will increase.
,C. The half-life of the second drug will increase.
D. There will be no change in the second drug’s metabolism.
Answer: A
Conceptual Explanation: Enzyme inducers increase the rate of drug metabolism, which
leads to lower plasma levels of the substrate drug and potentially reduced therapeutic
effect.
3. Which of the following describes the ‘First-Pass Effect’?
A. The rapid renal excretion of a drug after the first dose.
B. The binding of a drug to albumin during its first circuit through the blood.
C. The initial distribution of a drug to highly perfused organs like the heart.
D. The inactivation of oral drugs by liver enzymes before they reach systemic circulation.
Answer: D
Conceptual Explanation: The first-pass effect refers to the rapid hepatic inactivation of
certain oral drugs. When drugs are absorbed from the GI tract, they go directly to the liver
via the hepatic portal vein; if the liver has a high capacity to metabolize them, they can be
entirely inactivated.
4. A drug with a narrow therapeutic index (TI) requires which of the following clinical actions?
A. Minimal monitoring since the drug is very safe.
B. Administration of the drug only via the intravenous route.
, C. Frequent monitoring of serum drug levels to avoid toxicity.
D. Use of the drug only in emergency situations.
Answer: C
Conceptual Explanation: A narrow therapeutic index means the lethal or toxic dose is
close to the therapeutic dose. Therefore, careful monitoring of blood levels is necessary to
ensure safety.
5. Which receptor sub-type is primarily responsible for increasing heart rate and contractility?
A. Beta-1
B. Alpha-1
C. Beta-2
D. Muscarinic-2
Answer: A
Conceptual Explanation: Beta-1 receptors are located primarily in the heart. Activation
leads to increased heart rate (chronotropy) and increased force of contraction (inotropy).
6. What is the primary physiological effect of activating Alpha-1 receptors?
A. Vasodilation of skeletal muscle arterioles
B. Vasoconstriction of blood vessels
C. Bronchodilation
